Maryland-based drug discovery company Shuttle Pharma has announced the expansion of a Phase II trial of ropidoxuridine for glioblastoma patients as the first cohort is dosed at cancer centres ...

More information: Syeda Maheen Batool et al, Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas, Nature Communications (2024). DOI: 10.1038/s41467-024-51332-7 ...

Published recently in the journal Frontiers in Nutrition, the report is the first evaluation of the use of ketogenic metabolic therapy (KMT) without chemo or radiation interventions, on a patient ...